Royalty Pharma plc
NASDAQ:RPRX
25.85 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||
| Net Income
| 1,134.834 | 230.064 | 1,241.201 | 1,701.954 | 2,461.419 | 1,517.855 | 1,343.18 |
| Depreciation & Amortization
| 20.499 | 5.67 | 22.996 | 23.058 | 23.924 | 33.267 | 33.267 |
| Deferred Income Tax
| 0 | 0 | -1,522.363 | 65.49 | 0 | 0 | 0 |
| Stock Based Compensation
| 2.357 | 2.17 | 2.443 | 5.428 | 0 | 0 | 0 |
| Change In Working Capital
| 3,200.556 | 32.662 | -16.322 | -1,884.009 | -1,673.508 | -1,562.379 | -1,475.619 |
| Accounts Receivables
| 1.067 | 31.712 | -29.143 | -0.4 | 159.861 | 111.529 | -84.48 |
| Inventory
| 0 | -31.712 | 29.143 | 0.4 | -166.357 | 0 | 0 |
| Accounts Payables
| 6.236 | 2.286 | -4.586 | -0.766 | 6.496 | 1.35 | 0.517 |
| Other Working Capital
| 3,193.253 | 30.376 | -11.736 | -1,883.243 | -1,673.508 | -1,563.729 | -1,475.619 |
| Other Non Cash Items
| -1,370.444 | 1,873.414 | 2,289.581 | 2,122.708 | 855.404 | 1,629.574 | 1,517.485 |
| Operating Cash Flow
| 2,987.802 | 2,143.98 | 2,017.536 | 2,034.629 | 1,667.239 | 1,618.317 | 1,418.313 |
| Investing Activities: | |||||||
| Investments In Property Plant And Equipment
| 0 | 2,041.152 | 0.523 | 2,197 | -1,721.291 | 269.593 | -2,290.707 |
| Acquisitions Net
| -12.542 | -9.896 | -34.855 | -40 | -27.042 | -24.173 | -2 |
| Purchases Of Investments
| -2,115.522 | -2,565.068 | -3,593.656 | -3,937 | -2,363.651 | -422.403 | -2,300.707 |
| Sales Maturities Of Investments
| 25.831 | 1,545.543 | 1,776.308 | 1,203 | 524.551 | 750 | 600 |
| Other Investing Activites
| 29.444 | -2,041.152 | -18.6 | -2,182 | 1,471.291 | -269.593 | 115 |
| Investing Cash Flow
| -2,072.789 | -1,029.421 | -1,870.28 | -2,759 | -2,116.142 | 303.424 | -1,587.707 |
| Financing Activities: | |||||||
| Debt Repayment
| -1,000 | 0 | 1,272.533 | 680.634 | -294 | -294 | 907 |
| Common Stock Issued
| 0 | 0 | 0 | 1,908.744 | 0 | 0 | 0 |
| Common Stock Repurchased
| -304.759 | 0 | 0 | 0 | -4.266 | 0 | 0 |
| Dividends Paid
| -358.327 | -333.322 | -285.184 | -397.843 | -739.276 | -814.359 | -735.174 |
| Other Financing Activities
| -485.668 | -611.534 | -602.237 | -704.363 | -154.084 | -270.742 | -295.08 |
| Financing Cash Flow
| -2,148.754 | -944.856 | 385.112 | 1,487 | -1,191.626 | -1,379.101 | -123.254 |
| Other Information: | |||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.371 | 0 | 0 | 0 |
| Net Change In Cash
| -1,233.741 | 169.703 | 532.368 | 763 | -1,640.529 | 542.64 | -292.648 |
| Cash At End Of Period
| 477.01 | 1,710.751 | 1,541.048 | 1,009 | 283.682 | 1,924.211 | 1,381.571 |